Rigel Pharmaceuticals, Inc. (RIGL) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
17/25
Growth 5
Margin 3
Expansion 4
Platform 1
Financial 4
latest quarter score
Earnings Reports
- 17
- 22
- 19
- 23
- 17
- 23